Arcl Organics Ltd.
NSE: ARCL · Commodity Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 70 companies in Commodity Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹23 cr vs borrowings ₹71 cr (FY26): borrowings are higher by ₹48 cr.
- Operating profit covered interest 5.4x in the last 12 months.
- Net loss in 1 of the last 6 quarters.
- Other income was 39% of net profit in the last 12 months.
- No dividend in the last 3 financial years.
- Price ₹211.21 on 2026-10-26: -24.8% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 72 | 67 | 86 | 53 | 65 | 67 |
| EBITDA | 9 | 6 | 11 | -1 | 7 | 16 |
| OPM % | 12.4% | 9.6% | 13.2% | -1.6% | 10.9% | 23.3% |
| Other income | 0 | 1 | 1 | 1 | 1 | 1 |
| Net profit | 6 | 4 | 7 | -9 | 3 | 9 |
| EPS (₹) | 7.00 | 4.99 | 8.90 | 11.01 | 3.49 | 11.40 |
| Revenue YoY | -9.6% | -0.6% | ||||
| Profit YoY | -50.2% | +128.6% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 191 | 251 | 272 | 272 |
| EBITDA | 20 | 24 | 24 | 33 |
| Net profit | 11 | 12 | 5 | 10 |
| EPS (₹) | 13.38 | 15.42 | 6.49 | 34.80 |
| Revenue growth | +31.4% | +8.7% | – | |
| Profit growth | +15.2% | -57.9% | – | |
| Dividend / share (₹) | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 77 | 82 |
| Borrowings | 34 | 71 |
| Cash & equivalents | 18 | 23 |
| Total assets | 169 | 220 |
| Fixed assets | 68 | 97 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 52 | 41 |
| Inventory | 14 | 24 |
| Payables | 45 | 42 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 5 | -4 |
| Cash from investing | -9 | -34 |
| Cash from financing | 2 | 32 |
| Capex | 10 | 35 |
| Free cash flow | -5 | -39 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 15.9% | 6.3% |
| ROCE % | 18.8% | 14.4% |
| Debtor days | 75 | 56 |
| Inventory days | 28 | 45 |
| Payable days | 90 | 79 |
| Cash conversion cycle (days) | 13 | 22 |
| Working capital days | 47 | 33 |
Peers in Commodity Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SRF | ₹69,362 cr | 30.4x | 4.5x | 16.0% | 15.2% | 21.4% | +373.5% | 0.38% |
| TATACHEM | ₹15,184 cr | – | 0.7x | -10.1% | -4.2% | -1.6% | -4.6% | 1.84% |
| DEEPAKFERT | ₹14,422 cr | 14.7x | 2.1x | 15.1% | 13.6% | 16.7% | +0.6% | 0.89% |
| GNFC | ₹7,634 cr | 7.4x | 0.8x | 11.7% | 15.2% | 14.8% | -8.7% | 3.41% |
| TANFACIND | ₹4,989 cr | 66.3x | 13.4x | 19.7% | 20.5% | 15.5% | +23.8% | – |
| GUJALKALI | ₹4,043 cr | 60.9x | 0.8x | 1.2% | 3.6% | 11.3% | -1.2% | 2.88% |
| GRAUWEIL | ₹3,537 cr | 22.1x | 3.3x | 15.9% | 19.6% | 15.3% | +6.8% | 0.64% |
| GHCL | ₹3,486 cr | 6.7x | 1.0x | 14.9% | 19.9% | 24.8% | -12.3% | 3.29% |
| JGCHEM | ₹2,190 cr | 29.1x | 4.1x | 15.1% | 19.8% | 8.9% | – | 0.18% |
| ARCL | ₹169 cr | 6.1x | 2.0x | 12.9% | 20.1% | 12.2% | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Commodity Chemicals |
| Sub-industry | Commodity Chemicals |
| Symbol | ARCL |
| BSE code | 543993 |
| ISIN | INE372M01010 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.